Evaluation of therapeutic effect of intracordal bFGF administration on vocal fold paralysis

eha Rumi0 个研究点目标入组 31 人开始时间: 2023年3月3日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients aged 18 years or older (regardless of gender)
•(2) Patient diagnosed with unilateral vocal cord paralysis as a voice disorder
•(3) As for vocal cord paralysis, patients who are not expected to recover due to the transection of the vagus nerve or recurrent nerve, or patients after 6 months of onset of paralysis
•(4) Patients who wish to improve voice impairment due to vocal cord paralysis
•(5) Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study

•(1) Patients with obvious tumors on the vocal cords
•(2) Patients with malignant tumors anywhere in the body (cancer-bearing condition)
•(3) Patients with a history of malignant tumor on the vocal cords
•(4) Patients with a history of severe drug allergies or side effects
•(5) Patients with a history of hypersensitivity to trafermin (genetical recombination)
•(6) Pregnant, lactating, or possibly pregnant patients
•(7) Patients who are judged inappropriate for participation in this study by the principal investigator or co-investigator

发起方

eha Rumi